1. Home
  2. MLKN vs CDNA Comparison

MLKN vs CDNA Comparison

Compare MLKN & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MillerKnoll Inc.

MLKN

MillerKnoll Inc.

HOLD

Current Price

$16.21

Market Cap

1.0B

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$22.77

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLKN
CDNA
Founded
1905
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
1994
2007

Fundamental Metrics

Financial Performance
Metric
MLKN
CDNA
Price
$16.21
$22.77
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$28.00
AVG Volume (30 Days)
565.0K
583.8K
Earning Date
03-25-2026
04-28-2026
Dividend Yield
4.71%
N/A
EPS Growth
N/A
N/A
EPS
0.98
0.05
Revenue
$3,669,900,000.00
$48,324,000.00
Revenue This Year
$5.94
$16.01
Revenue Next Year
$3.78
$11.31
P/E Ratio
$16.82
$455.40
Revenue Growth
1.14
18.93
52 Week Low
$13.77
$10.96
52 Week High
$23.18
$23.24

Technical Indicators

Market Signals
Indicator
MLKN
CDNA
Relative Strength Index (RSI) 53.81 65.92
Support Level $13.87 $15.80
Resistance Level $16.34 $22.89
Average True Range (ATR) 0.57 0.95
MACD 0.20 0.11
Stochastic Oscillator 86.96 90.52

Price Performance

Historical Comparison
MLKN
CDNA

About MLKN MillerKnoll Inc.

MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: